Interestingly, while most of the NSCLC patients studied were current smokers, cancer cells with AhR and AhRR expression, which is activated by the many components/carcinogens of tobacco smoke and, therefore, may be used as a biomarker of lung cancer development, were not identified in our work. The gene discussed is AHRR; the disease is non-small cell lung carcinoma.